Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001676051-16-000003
Filing Date
2016-06-14
Accepted
2016-06-14 17:49:04
Documents
1
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 30093
  Complete submission text file 0001676051-16-000003.txt   31609
Mailing Address 3301 AGRICULTURE DRIVE MADISON WI 53716
Business Address 3301 AGRICULTURE DRIVE MADISON WI 53716 617-244-1616
Cellectar Biosciences, Inc. (Issuer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1329 STRATFORD COURT DEL MAR CA 92014
Business Address
Hertzberg Richard (Reporting) CIK: 0001676051 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36598 | Film No.: 161713917